Literature DB >> 26380724

Illuminating anthracycline cardiotoxicity: the renaissance of evidence-based onco-cardiology.

Isaac B Rhea1, Guilherme H Oliveira1.   

Abstract

Entities:  

Year:  2015        PMID： 26380724      PMCID： PMC4522509          DOI： 10.3978/j.issn.2072-1439.2015.07.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  8 in total

1.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  J Am Soc Echocardiogr       Date:  2014-09       Impact factor: 5.251

2.  Clinical trials with adriamycin.

Authors:  E Middleman; J Luce; E Frei
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

3.  Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giulia Bacchiani; Ines Tedeschi; Carlo A Meroni; Fabrizio Veglia; Maurizio Civelli; Giuseppina Lamantia; Nicola Colombo; Giuseppe Curigliano; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2015-05-06       Impact factor: 29.690

4.  Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Authors:  G Curigliano; D Cardinale; T Suter; G Plataniotis; E de Azambuja; M T Sandri; C Criscitiello; A Goldhirsch; C Cipolla; F Roila
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 5.  Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.

Authors:  M Aapro; C Bernard-Marty; E G C Brain; G Batist; F Erdkamp; K Krzemieniecki; R Leonard; A Lluch; S Monfardini; M Ryberg; P Soubeyran; U Wedding
Journal:  Ann Oncol       Date:  2010-10-18       Impact factor: 32.976

6.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

Review 7.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

Authors:  Edward T H Yeh; Courtney L Bickford
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

Review 8.  Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment.

Authors:  Maria Volkova; Raymond Russell
Journal:  Curr Cardiol Rev       Date:  2011-11
  8 in total
  2 in total

Review 1.  Metastatic and triple-negative breast cancer: challenges and treatment options.

Authors:  Sumayah Al-Mahmood; Justin Sapiezynski; Olga B Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Bioactive nanotherapeutic trends to combat triple negative breast cancer.

Authors:  Pallabita Chowdhury; Upasana Ghosh; Kamalika Samanta; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Bioact Mater       Date:  2021-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.